Skip to main content

Here are five things you must know for Wednesday, Nov. 13: 

1. -- Stock Futures Fall Amid Trade Confusion

U.S. stock futures fell Wednesday following a speech from Donald Trump that created confusion over the state of U.S.-China trade talks and raised the prospect of tariff increases if the two sides fail to reach a near-term agreement.

Trump's address to the Economic Club of New York, which was expected to focus on trade, turned out to be far more of a political stump speech that highlighted his administration's financial achievements and renewed his attack on the Federal Reserve. Jerome Powell, Federal Reserve chairman, will address a congressional committee Wednesday on the economic outlook for the U.S.

What was mentioned about trade amounted to little more than soundbites the president has repeated for most of the past few months, including the assessment that China is "dying to make a deal" and that a "a significant phase one trade deal with China could happen soon." However, he also threatened "very substantial" tariffs on China-made goods if a deal wasn't reached, raising the prospect that levies on $175 billion worth of consumer goods will kick in on Dec. 15.

Contracts tied to the Dow Jones Industrial Average declined 107 points, futures for the S&P 500 were down 11.90 points, and Nasdaq futures fell 40 points.

Trump's speech Tuesday had little impact on U.S. markets which finished mixed but saw the Nasdaq rise 0.26% to close at a record high of 8,486.09.

2. -- Jerome Powell, CPI and Cisco Earnings Are Wednesday's Highlights

The economic calendar in the U.S. Wednesday includes the Consumer Price Index for October at 8:30 a.m. ET. Economists surveyed by FactSet expect consumer prices last month to have risen 0.3%, with the year-over-year-gain at 1.7%. Core CPI, which excludes food and energy costs, for the year is expected to remain steady at 2.4%.

Federal Reserve Chairman Jerome Powell is scheduled to testify before the Congressional Joint Economic Committee in a hearing on "The Economic Outlook" in Washington at 11 a.m.

Earnings reports are expected Wednesday from Cisco Systems (CSCO) , Canada Goose (GOOS) , Luckin Coffee (LK) , NetApp (NTAP)  and  (CTRP) .

Cisco Systems is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells shares of the stock? Learn more now.

3. -- Nike to Stop Selling Directly on Amazon's Website

Nike (NKE)  will stop selling its sneakers and apparel directly on's (AMZN) website, ending a pilot program that began in 2017.

"As part of Nike's focus on elevating consumer experiences through more direct, personal relationships, we have made the decision to complete our current pilot with Amazon Retail," the sports apparel giant said in a statement. "We will continue to invest in strong, distinctive partnerships for Nike with other retailers
and platforms to seamlessly serve our consumers globally."

Bloomberg, which first reported the news, noted the Nike-Amazon split comes amid a massive overhaul of Nike's retail
strategy, and also follows the hiring of John Donahoe, eBay's ex-CEO, as its new chief executive.

Nike said it would continue to use Amazon's cloud-computing unit, Amazon Web Services, to power its apps and services, Bloomberg reported.

Amazon is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells shares of AMZN? Learn more now.

4. -- Google's 'Project Nightingale' Draws Scrutiny From Federal Regulators

Google's project to collect health data on millions of patients without their or their doctor's knowledge is drawing scrutiny from federal regulators, The Wall Street Journal reported.

The so-called Project Nightingale project between Alphabet's (GOOGL) Google unit and hospital operator Ascension, the country's second-largest health system,  gained attention Tuesday after the Journal reported the data was being collected without patient knowledge or consent.

Ascension, without notifying patients or doctors, has begun sharing with Google personally identifiable information on millions of patients, such as names and dates of birth; lab tests; doctor diagnoses; medication and hospitalization history; and some billing claims and other clinical records, according to the Journal.

The office of Civil Rights at the Department of Health and Human Services has launched a probe of the project, the Journal reported late Tuesday. The investigation "will seek to learn more information about this mass collection of individuals' medical records to ensure that HIPAA protections were fully implemented," director Roger Severino said in a statement.

The Street's Jim Cramer, in this video, said the news surrounding Google's secret project won't be going away anytime soon. 

Alphabet is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells the stock? Learn more now.

5. -- Tilray Tumbles as Loss Is Wider Than Forecasts

Tilray (TLRY)  fell 2.92% in premarket trading Wednesday to $20.94 after the cannabis company reported a third-quarter loss that was wider than analysts' estimates.

Tilray reported an adjusted loss of 50 cents a share, compared with analysts' estimates that called for a loss of 30 cents, according to Bloomberg.

Revenue in the quarter jumped 400% to $51.1 million and topped estimates of $49.4 million. The company sold 10.8 metric tons of cannabis at an average selling price of $3.25 a gram, down from $6.21 per gram a year earlier.

"Our performance in the third quarter, including solid revenue growth and sequential gross margin expansion, reflects the positive business trends we have underway," said Brendan Kennedy, Tilray's president and CEO. "We are in the early days of seeing our strategic initiatives bear fruit - including our European expansion, brand portfolio evolution and strategic partnership product launches."